Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab

Liver Transplant ◽

Bowel Disease ◽

Clinical Remission ◽

Sclerosing Cholangitis ◽

DOP033. Efficacy and safety of anti-TNF therapy for inflammatory bowel disease (IBD) in liver transplant recipients for primary sclerosing cholangitis (PSC): a multicenter experience.

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jju027.061 ◽

2015 ◽

Vol 9 (suppl 1) ◽

pp. S40-S40 ◽

Cited By ~ 1

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Efficacy And Safety ◽

Transplant Recipients ◽

Inflammatory Bowel ◽

S1017 Colonoscopic Surveillance in Inflammatory Bowel Disease Post Liver Transplant for Primary Sclerosing Cholangitis

Gastroenterology ◽

10.1016/s0016-5085(09)63752-5 ◽

2009 ◽

Vol 136 (5) ◽

pp. A-814

Author(s):

Gokulan Pavendranathan ◽

Warwick Selby ◽

Nicholas A. Shackel ◽

Simone I. Strasser ◽

Geoffrey W. McCaughan ◽

...

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Colonoscopic Surveillance ◽

Tu1345 Efficacy and Safety of Anti-TNF Therapy for Inflammatory Bowel Disease (IBD) in Liver Transplant Recipients for Primary Sclerosing Cholangitis (PSC): A Multicenter Experience

Gastroenterology ◽

10.1016/s0016-5085(15)32932-2 ◽

2015 ◽

Vol 148 (4) ◽

pp. S-865

Author(s):

Roman Combes ◽

Romain Altwegg ◽

David Laharie ◽

Victor de Ledinghen ◽

Sylvie Radenne ◽

...

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Efficacy And Safety ◽

Transplant Recipients ◽

Inflammatory Bowel ◽

Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study

Digestive and Liver Disease ◽

10.1016/j.dld.2020.09.011 ◽

2020 ◽

Author(s):

Davide Giuseppe Ribaldone ◽

Nicola Imperatore ◽

Marco Le Grazie ◽

Federica Furfaro ◽

Paola Balestrieri ◽

...

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Disease Course ◽

Transplant Patients ◽

Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series

Digestive and Liver Disease ◽

10.1016/j.dld.2018.02.014 ◽

2018 ◽

Vol 50 (7) ◽

pp. 668-674 ◽

Cited By ~ 8

Author(s):

Romain Altwegg ◽

Roman Combes ◽

David Laharie ◽

Victor De Ledinghen ◽

Sylvie Radenne ◽

...

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Case Series ◽

Transplant Recipients ◽

Inflammatory Bowel ◽

Sa1932 Inflammatory Bowel Disease Activity in Patients Undergoing Liver Transplant for Primary Sclerosing Cholangitis

Gastroenterology ◽

10.1016/s0016-5085(16)31420-2 ◽

2016 ◽

Vol 150 (4) ◽

pp. S407-S408

Author(s):

Ravish Parekh ◽

Cristina Segovia ◽

Nirmal Kaur

Keyword(s):

Liver Transplant ◽

Disease Activity ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

The Impact of Biological Therapy on Liver Transplant Outcomes in Pvvvatients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

The American Journal of Gastroenterology ◽

10.14309/00000434-201510001-01995 ◽

2015 ◽

Vol 110 ◽

pp. S844

Author(s):

Gursimran Kochhar ◽

Ahyoung Kim ◽

Ramprasad Jegadeesan ◽

Andrea Fialho ◽

Andre Fialho ◽

...

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Biological Therapy ◽

Transplant Outcomes ◽

Inflammatory Bowel ◽

The Impact

Tu1564 – Predictors of Outcome and Rate of Graft Failure in Patients with Primary Sclerosing Cholangitis Due to Inflammatory Bowel Disease After Receiving Liver Transplant. A Descriptive Study from the United Network of Organ Sharing (UNOS) Database

Gastroenterology ◽

10.1016/s0016-5085(19)40423-x ◽

2019 ◽

Vol 156 (6) ◽

pp. S-1359-S-1360

Author(s):

Ahmed Rahma ◽

Sarah Aurit ◽

Renuga Vivekanandan ◽

Ryan W. Walters ◽

ali h. osman ◽

...

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Graft Failure ◽

Descriptive Study ◽

Predictors Of Outcome ◽

Inflammatory Bowel ◽

United Network

Su1855 – Vedolizumab is Not Associated with Increased Infection Risk in Immunosuppressed Liver Transplant Recipients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Gastroenterology ◽

10.1016/s0016-5085(19)38492-6 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-636

Author(s):

Chung Sang Tse ◽

Edward V. Loftus ◽

Laura H. Raffals ◽

Amy L. Lightner

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Infection Risk ◽

Transplant Recipients ◽

Inflammatory Bowel ◽

Survival Outcomes of Liver Transplant Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

The American Journal of Gastroenterology ◽

10.14309/00000434-201710001-00915 ◽

2017 ◽

Vol 112 ◽

pp. S511-S513

Author(s):

Omar Y. Mousa ◽

Neej J. Patel ◽

Maoyin Pang ◽

Sarah M. Nimri ◽

Denise Harnois

Keyword(s):

Liver Transplant ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Survival Outcomes ◽

Transplant Patients ◽